Demographic characteristics | Five-year survival rate | HR (95% CI) | P value |
---|---|---|---|
Age (year) | |||
 • < 45 | 21.2% | Ref | - |
 • 45–65 | 30.7% | 0.66 (0.59,0.73) | 0.001 |
 • > 65 | 21.4% | 0.99 (0.55, 2.84) | 0.81 |
BMI (Kg/m2) | |||
 • ≤ 18 | 18.4% | Ref | - |
 • 18–25 | 29.8% | 0.71 (0.60,0.83) | 0.001 |
 • > 25 | 23.2% | 0.96 (0.71, 1.15) | 0.087 |
Sex | Â | Â | 0.25 |
 • Male | 24.9% | - |  |
 • Female | 26.9% |  |  |
Marital status | Â | Â | 0.54 |
 • Unmarried | 27.2% | - |  |
 • Married | 25.2% |  |  |
Smoking status | Â | Â | 0.61 |
 • Yes | 24.8% | - |  |
 • NO | 26.1% |  |  |
Education | Â | Â | Â |
 • Illiterate | 25.3% | - | 0.81 |
 • < Diploma | 24.2% |  |  |
 • >  = Diploma | 26.1% |  |  |
Family history of GC | Â | Â | 0.12 |
 • No | 27.2% |  |  |
 • Yes | 25.2% |  |  |
Alcohol consumption | Â | Â | 0.44 |
 • No | 26.6 |  |  |
 • Yes | 24.8 |  |  |
 • Unknown & missing | 25.4 |  |  |
Child–Pugh stage |  |  | 0.12 |
 • A | 28.1 | - |  |
 • B | 24.7 |  |  |
 • Unknown & missing | 26.2 |  |  |
Tumor size (cm) | |||
 • ≤ 5 | 32.5% | Ref | - |
 • > 5 | 18.9% | 1.73 (1.12,2.25) | 0.001 |
 • Unknown & missing | 21.1% | 1.48 (0.99,2.11) | 0.074 |
Metastasis | |||
 • No | 31.6% | Ref | - |
 • Yes | 21.2% | 1.52 (1.11, 1.93) | 0.001 |
 • Unknown & missing | 23.8% | 1.32 (1.06,1.6) | 0.004 |
Involved Lymph node | |||
 • < 2 | 32.9% | Ref | - |
 • ≥ 2 | 20.11% | 1.65 (1.16,2.17) | 0.001 |
 • Unknown & missing | 24.6% | 1.31 (1.04,1.62) | 0.026 |
Differentiation grade | |||
 • Well | 33.2% | Ref | - |
 • Moderate | 24.3% | 1.36 (1.08,1.65) | 0.006 |
 • Poor | 17.2% | 1.94 (1.44,2.46) | 0.0001 |
 • Unknown & missing | 25.1% | 1.30 (1.01,1.62) | 0.043 |
Serum AFP level | |||
 • < 400 ng/ml | 30.1% | Ref | - |
 • ≥ 400 ng/ml | 20.4% | 1.51 (1.12, 1.93) | 0.0001 |
 • Unknown & missing | 25.6% | 1.17 (0.96,1.43) | 0.098 |
Cirrhosis | Â | Â | 0.24 |
 • Yes | 26.6% | - |  |
 • No | 24.7% |  |  |
 • Unknown & missing | 25.3% |  |  |
ABO Blood Type | |||
 • O | 31.1% | Ref | - |
 • A | 12.9% | 2.41 (1.66,3.17) | 0.001 |
 • B | 24.1% | 1.29 (1.02,1.56) | 0.045 |
 • AB | 29.2% | 1.06 (0.86, 1.121) | 0.18 |
ABO Blood Type | Â | Â | 0.001 |
 • Non-A | 29.7% | Ref |  |
 • A | 12.9% | 2.3 (1.46,3.15) |  |
Hepatitis type | |||
 • None | 28.3% | Ref | - |
 • HBV | 20.14% | 1.41 (1.02,1.81) | 0.008 |
 • HCV | 25.1% | 1.13 (0.97, 1.3) | 0.084 |
 • HBV + HCV | 19.1% | 1.42 (0.98,1.89) | 0.092 |
 • Unknown & missing | 22.4% | 1.25 (0.92, 1.59) | 0.11 |
Hepatitis type | Â | Â | 0.013 |
 • Non-HBV | 26.3% | Ref |  |
 • HBV | 20.14% | 1.29 (1.04,1.55) |  |
RH | Â | - | 0.88 |
 • +  | 25.8% |  |  |
 • - | 25.3% |  |  |